Matches in SemOpenAlex for { <https://semopenalex.org/work/W2773772443> ?p ?o ?g. }
- W2773772443 abstract "Recent data conflict on the clinical efficacy of later-generation fluoroquinolones, such as moxifloxacin or levofloxacin, for the treatment of multidrug-resistant tuberculosis (MDR-TB) that is resistant to ofloxacin but susceptible to moxifloxacin. The purpose of the present study was to evaluate whether later-generation fluoroquinolones can improve treatment outcomes in patients with ofloxacin-resistant, moxifloxacin-susceptible MDR-TB. A retrospective cohort study was performed on 208 patients with moxifloxacin-susceptible MDR-TB who were treated between 2006 and 2011. Later-generation fluoroquinolones were used for all patients. Overall, 171 patients (82%) had ofloxacin-susceptible, moxifloxacin-susceptible MDR-TB (ofloxacin-susceptible group), and 37 (18%) had ofloxacin-resistant, moxifloxacin-susceptible MDR-TB (ofloxacin-resistant group). Compared to the ofloxacin-susceptible group, the ofloxacin-resistant group was more likely to have a history of MDR-TB treatment (P < 0.001) and cavitary lesions on chest radiography (P < 0.001). In addition, the ofloxacin-resistant group was more likely than the ofloxacin-susceptible group to have resistance to the drugs pyrazinamide (P = 0.003), streptomycin (P = 0.015), prothionamide (P < 0.001), and para-aminosalicylic acid (P < 0.001). Favorable outcomes were more frequently achieved for the ofloxacin-susceptible group than for the ofloxacin-resistant group (91% [156/171] versus 57% [21/37], respectively [P < 0.001]). In multivariable regression logistic analysis, the ofloxacin-susceptible group was about 5.36 (95% confidence interval, 1.55 to 18.53) times more likely than the ofloxacin-resistant group (P < 0.001) to have favorable outcomes. Despite in vitro moxifloxacin susceptibility, the frequency of favorable treatment outcomes for ofloxacin-resistant MDR-TB was significantly lower than that for ofloxacin-susceptible MDR-TB, even when later-generation fluoroquinolones were used, indicating that more-aggressive therapies may be needed for ofloxacin-resistant MDR-TB." @default.
- W2773772443 created "2017-12-22" @default.
- W2773772443 creator A5001018391 @default.
- W2773772443 creator A5011892284 @default.
- W2773772443 creator A5021693494 @default.
- W2773772443 creator A5023794901 @default.
- W2773772443 creator A5032320239 @default.
- W2773772443 creator A5038057658 @default.
- W2773772443 creator A5039766735 @default.
- W2773772443 creator A5081468898 @default.
- W2773772443 creator A5090050510 @default.
- W2773772443 date "2018-02-01" @default.
- W2773772443 modified "2023-10-14" @default.
- W2773772443 title "Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis" @default.
- W2773772443 cites W1935704864 @default.
- W2773772443 cites W1965021247 @default.
- W2773772443 cites W1970003721 @default.
- W2773772443 cites W1974647584 @default.
- W2773772443 cites W1996794817 @default.
- W2773772443 cites W1997031439 @default.
- W2773772443 cites W2007026404 @default.
- W2773772443 cites W2022770335 @default.
- W2773772443 cites W2050326181 @default.
- W2773772443 cites W2051110950 @default.
- W2773772443 cites W2052166920 @default.
- W2773772443 cites W2082004384 @default.
- W2773772443 cites W2095281873 @default.
- W2773772443 cites W2098413564 @default.
- W2773772443 cites W2121318437 @default.
- W2773772443 cites W2123602067 @default.
- W2773772443 cites W2128057974 @default.
- W2773772443 cites W2132242431 @default.
- W2773772443 cites W2145441337 @default.
- W2773772443 cites W2145810864 @default.
- W2773772443 cites W2156941948 @default.
- W2773772443 cites W2177680624 @default.
- W2773772443 cites W2238396700 @default.
- W2773772443 cites W2255884538 @default.
- W2773772443 cites W2283318700 @default.
- W2773772443 cites W2395879529 @default.
- W2773772443 cites W2512849301 @default.
- W2773772443 cites W2547537072 @default.
- W2773772443 cites W2594453913 @default.
- W2773772443 cites W2602169678 @default.
- W2773772443 cites W2603888074 @default.
- W2773772443 cites W2611433191 @default.
- W2773772443 cites W2617726015 @default.
- W2773772443 cites W2737625052 @default.
- W2773772443 cites W2740681594 @default.
- W2773772443 doi "https://doi.org/10.1128/aac.01784-17" @default.
- W2773772443 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5786783" @default.
- W2773772443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29203478" @default.
- W2773772443 hasPublicationYear "2018" @default.
- W2773772443 type Work @default.
- W2773772443 sameAs 2773772443 @default.
- W2773772443 citedByCount "8" @default.
- W2773772443 countsByYear W27737724432018 @default.
- W2773772443 countsByYear W27737724432019 @default.
- W2773772443 countsByYear W27737724432020 @default.
- W2773772443 countsByYear W27737724432022 @default.
- W2773772443 countsByYear W27737724432023 @default.
- W2773772443 crossrefType "journal-article" @default.
- W2773772443 hasAuthorship W2773772443A5001018391 @default.
- W2773772443 hasAuthorship W2773772443A5011892284 @default.
- W2773772443 hasAuthorship W2773772443A5021693494 @default.
- W2773772443 hasAuthorship W2773772443A5023794901 @default.
- W2773772443 hasAuthorship W2773772443A5032320239 @default.
- W2773772443 hasAuthorship W2773772443A5038057658 @default.
- W2773772443 hasAuthorship W2773772443A5039766735 @default.
- W2773772443 hasAuthorship W2773772443A5081468898 @default.
- W2773772443 hasAuthorship W2773772443A5090050510 @default.
- W2773772443 hasBestOaLocation W27737724431 @default.
- W2773772443 hasConcept C126322002 @default.
- W2773772443 hasConcept C142724271 @default.
- W2773772443 hasConcept C2778049240 @default.
- W2773772443 hasConcept C2778512257 @default.
- W2773772443 hasConcept C2778607973 @default.
- W2773772443 hasConcept C2778836808 @default.
- W2773772443 hasConcept C2780459521 @default.
- W2773772443 hasConcept C2781069245 @default.
- W2773772443 hasConcept C2781276175 @default.
- W2773772443 hasConcept C3019249092 @default.
- W2773772443 hasConcept C501593827 @default.
- W2773772443 hasConcept C71924100 @default.
- W2773772443 hasConcept C86803240 @default.
- W2773772443 hasConcept C89423630 @default.
- W2773772443 hasConceptScore W2773772443C126322002 @default.
- W2773772443 hasConceptScore W2773772443C142724271 @default.
- W2773772443 hasConceptScore W2773772443C2778049240 @default.
- W2773772443 hasConceptScore W2773772443C2778512257 @default.
- W2773772443 hasConceptScore W2773772443C2778607973 @default.
- W2773772443 hasConceptScore W2773772443C2778836808 @default.
- W2773772443 hasConceptScore W2773772443C2780459521 @default.
- W2773772443 hasConceptScore W2773772443C2781069245 @default.
- W2773772443 hasConceptScore W2773772443C2781276175 @default.
- W2773772443 hasConceptScore W2773772443C3019249092 @default.
- W2773772443 hasConceptScore W2773772443C501593827 @default.
- W2773772443 hasConceptScore W2773772443C71924100 @default.
- W2773772443 hasConceptScore W2773772443C86803240 @default.
- W2773772443 hasConceptScore W2773772443C89423630 @default.